Catabasis Pharmaceuticals, Inc.
FATTY ACID CYSTEAMINE CONJUGATES AND THEIR USE AS ACTIVATORS OF AUTOPHAGY
Last updated:
Abstract:
The invention relates to fatty acid cysteamine conjugates, compositions comprising a fatty acid cysteamine conjugate, and methods for using such conjugates and compositions to treat disease, such as a disease caused by dysregulation of autophagy.
Status:
Application
Type:
Utility
Filling date:
8 Apr 2019
Issue date:
6 Feb 2020